Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Olmesartan Medoxomil MeSH Descriptor Data 2026


MeSH Heading
Olmesartan Medoxomil
Tree Number(s)
D03.383.129.308.674
D03.383.129.617.584
Unique ID
D000068557
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068557
Scope Note
An ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to manage HYPERTENSION.
Entry Term(s)
5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346
Benicar
CS 866
CS-866
Olmetec
Votum
Pharm Action
Antihypertensive Agents
Angiotensin II Type 1 Receptor Blockers
Registry Numbers
6M97XTV3HD
0
Related Numbers
144689-24-7
Public MeSH Note
2016; OLMESARTAN MEDOXOMIL was indexed under IMIDAZOLES 1996-2015, and under TETRAZOLES 1996-2015
History Note
2016 (1996)
Date Introduced
2016/01/01
Last Updated
2018/03/01
Olmesartan Medoxomil Preferred
CS 866 Narrower
Benicar Narrower
Votum Narrower
Olmetec Narrower
page delivered in 0.141s